Sime Brkic
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
TLD: An optimized liposomal doxorubicin formulation with small vesicle size for improved anti-tumor efficacy.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 03, 2025
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable.
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 20, 2023
Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
Journal: Current oncology (Toronto, Ont.)
Published: December 31, 2021
Interferon-γ resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cells.
Journal: Developmental cell
Published: November 16, 2021
Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms.
Journal: HemaSphere
Published: July 20, 2020
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms.
Journal: The Journal of clinical investigation
Published: November 20, 2017
EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
Journal: EMBO reports
Published: August 23, 2017
VEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin-1+ monocyte/TGF-β1 paracrine axis.
Journal: EMBO molecular medicine
Published: September 02, 2015
Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicine.
Journal: Frontiers in bioengineering and biotechnology
Published: January 20, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026